Insulin glargine and OnabotulinumtoxinA Injection
Determining the interaction of Insulin glargine and OnabotulinumtoxinA Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: onabotulinumtoxinA
Brand name: Botox, Botox Cosmetic
Synonyms: OnabotulinumtoxinA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Onabotulinumtoxina Intramuscular
- Insulin glargine-Onasemnogene Abeparvovcec Infusion
- Insulin glargine-Onasemnogene Abeparvovec
- Insulin glargine-Onasemnogene abeparvovec Zolgensma
- Insulin glargine-Oncaspar
- Insulin glargine-Oncovin
- OnabotulinumtoxinA Injection-Insulin Glargine (U-100) Cartridge Systems and Pens
- OnabotulinumtoxinA Injection-Insulin Glargine (U-100) Vials
- OnabotulinumtoxinA Injection-Insulin Glargine (U-300) Pens
- OnabotulinumtoxinA Injection-Insulin glargine and lixisenatide
- OnabotulinumtoxinA Injection-Insulin glargine and lixisenatide Subcutaneous
- OnabotulinumtoxinA Injection-Insulin glargine, recombinant Subcutaneous